ADC Therapeutics (ADCT) PT Raised to $21 at H.C. Wainwright

September 19, 2022 6:47 AM EDT Send to a Friend
H.C. Wainwright analyst Robert Burns raised the price target on ADC Therapeutics (NYSE: ADCT) to $21.00 (from $20.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login